Next |
home / stock / abt / abt message board
Subject | By | Source | When |
---|---|---|---|
$ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
$ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
$ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
FDA clears $ABT's standalone glucose reader from FreestyleLibre: | DewDiligence | investorshub | 04/14/2023 2:06:15 PM |
FDA enables integration of FreeStyle Libre with automated insulin delivery syste | DewDiligence | investorshub | 03/06/2023 5:20:07 PM |
$ABT TriClip (tricuspid-value clip) highlighted at ACC | DewDiligence | investorshub | 03/06/2023 1:15:06 AM |
$ABT acquires CSII for $20/sh casha 50% premium | DewDiligence | investorshub | 02/08/2023 11:23:33 PM |
$ABT reports 4Q22 resultsissues 2023 guidance: | DewDiligence | investorshub | 01/25/2023 1:58:21 PM |
$ABT CEO at$ JPM: Libre will become a | DewDiligence | investorshub | 01/10/2023 5:23:24 PM |
$ABT increases dividend for 51st(!) consecutive year: | DewDiligence | investorshub | 12/09/2022 6:34:55 PM |
$ABT 3Q22 CC transcript: | DewDiligence | investorshub | 10/19/2022 11:34:13 PM |
Yes sir Dew, I was nit taking a | wiwineguy | investorshub | 10/19/2022 1:57:13 PM |
From my post earlier today: The stock is | DewDiligence | investorshub | 10/19/2022 1:52:55 PM |
And yet its selling off like crazy | wiwineguy | investorshub | 10/19/2022 1:47:41 PM |
$ABT 3Q22 Results by Business Segment | DewDiligence | investorshub | 10/19/2022 1:31:25 PM |
$ABT reports 3Q22 resultsraises 2022 EPS guidance: | DewDiligence | investorshub | 10/19/2022 1:30:52 PM |
$ABTs TCT presentations: | DewDiligence | investorshub | 09/19/2022 12:12:53 AM |
$ABT 2Q22 CC transcript: | DewDiligence | investorshub | 07/20/2022 4:54:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it coul...
2024-05-08 07:16:00 ET Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-tr...
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee PR Newswire More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ B...